NCT07489573 Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa Status RECRUITING Phase PHASE4
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE4
NCT07138898 Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty Status RECRUITING Phase PHASE2
NCT06905288 Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. Status RECRUITING Phase N/A
NCT06751238 Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). Status RECRUITING Phase PHASE1
NCT06331312 Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05622708 A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04179175 Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa Status COMPLETED Phase PHASE3